These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 14613275)

  • 1. The release of crosslinked peptides from type II collagen into human synovial fluid is increased soon after joint injury and in osteoarthritis.
    Lohmander LS; Atley LM; Pietka TA; Eyre DR
    Arthritis Rheum; 2003 Nov; 48(11):3130-9. PubMed ID: 14613275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in Cytokines and Aggrecan ARGS Neoepitope in Synovial Fluid and Serum and in C-Terminal Crosslinking Telopeptide of Type II Collagen and N-Terminal Crosslinking Telopeptide of Type I Collagen in Urine Over Five Years After Anterior Cruciate Ligament Rupture: An Exploratory Analysis in the Knee Anterior Cruciate Ligament, Nonsurgical Versus Surgical Treatment Trial.
    Struglics A; Larsson S; Kumahashi N; Frobell R; Lohmander LS
    Arthritis Rheumatol; 2015 Jul; 67(7):1816-25. PubMed ID: 25914389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procollagen II C-propeptide in joint fluid: changes in concentration with age, time after knee injury, and osteoarthritis.
    Lohmander LS; Yoshihara Y; Roos H; Kobayashi T; Yamada H; Shinmei M
    J Rheumatol; 1996 Oct; 23(10):1765-9. PubMed ID: 8895155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in joint cartilage aggrecan after knee injury and in osteoarthritis.
    Lohmander LS; Ionescu M; Jugessur H; Poole AR
    Arthritis Rheum; 1999 Mar; 42(3):534-44. PubMed ID: 10088777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tenascin-C levels in synovial fluid are elevated after injury to the human and canine joint and correlate with markers of inflammation and matrix degradation.
    Chockalingam PS; Glasson SS; Lohmander LS
    Osteoarthritis Cartilage; 2013 Feb; 21(2):339-45. PubMed ID: 23142724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of nitrotyrosine as a biomarker for arthritis and joint injury.
    Misko TP; Radabaugh MR; Highkin M; Abrams M; Friese O; Gallavan R; Bramson C; Hellio Le Graverand MP; Lohmander LS; Roman D
    Osteoarthritis Cartilage; 2013 Jan; 21(1):151-6. PubMed ID: 23025928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuated synovial fluid ghrelin levels are linked with cartilage damage, meniscus injury, and clinical symptoms in patients with knee anterior cruciate ligament deficiency.
    Zou YC; Chen LH; Ye YL; Yang GG; Mao Z; Liu DD; Chen JQ; Chen JJ; Liu G
    Discov Med; 2016 Dec; 22(123):325-335. PubMed ID: 28147215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of collagen type II and proteoglycans in the synovial fluids of patients diagnosed with non-infectious knee joint synovitis indicates early damage to the articular cartilage matrix.
    Elsaid KA; Jay GD; Chichester CO
    Osteoarthritis Cartilage; 2003 Sep; 11(9):673-80. PubMed ID: 12954238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage.
    Garnero P; Piperno M; Gineyts E; Christgau S; Delmas PD; Vignon E
    Ann Rheum Dis; 2001 Jun; 60(6):619-26. PubMed ID: 11350852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal patterns of stromelysin-1, tissue inhibitor, and proteoglycan fragments in human knee joint fluid after injury to the cruciate ligament or meniscus.
    Lohmander LS; Roos H; Dahlberg L; Hoerrner LA; Lark MW
    J Orthop Res; 1994 Jan; 12(1):21-8. PubMed ID: 8113939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
    Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
    Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal and cross-sectional variability in markers of joint metabolism in patients with knee pain and articular cartilage abnormalities.
    Lohmander LS; Dahlberg L; Eyre D; Lark M; Thonar EJ; Ryd L
    Osteoarthritis Cartilage; 1998 Sep; 6(5):351-61. PubMed ID: 10197170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of articular cartilage degradation and loss of boundary-lubricating ability of synovial fluid following injury and inflammatory arthritis.
    Elsaid KA; Jay GD; Warman ML; Rhee DK; Chichester CO
    Arthritis Rheum; 2005 Jun; 52(6):1746-55. PubMed ID: 15934070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased concentrations of bone sialoprotein in joint fluid after knee injury.
    Lohmander LS; Saxne T; Heinegård D
    Ann Rheum Dis; 1996 Sep; 55(9):622-6. PubMed ID: 8882132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis.
    Garnero P; Ayral X; Rousseau JC; Christgau S; Sandell LJ; Dougados M; Delmas PD
    Arthritis Rheum; 2002 Oct; 46(10):2613-24. PubMed ID: 12384919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Release of cartilage oligomeric matrix protein (COMP) into joint fluid after knee injury and in osteoarthritis.
    Lohmander LS; Saxne T; Heinegård DK
    Ann Rheum Dis; 1994 Jan; 53(1):8-13. PubMed ID: 8311563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis.
    Charni N; Juillet F; Garnero P
    Arthritis Rheum; 2005 Apr; 52(4):1081-90. PubMed ID: 15818703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type II collagen C2C epitope in human synovial fluid and serum after knee injury--associations with molecular and structural markers of injury.
    Kumahashi N; Swärd P; Larsson S; Lohmander LS; Frobell R; Struglics A
    Osteoarthritis Cartilage; 2015 Sep; 23(9):1506-12. PubMed ID: 25937025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A longitudinal study of cartilage matrix metabolism in patients with cruciate ligament rupture--synovial fluid concentrations of aggrecan fragments, stromelysin-1 and tissue inhibitor of metalloproteinase-1.
    Dahlberg L; Fridén T; Roos H; Lark MW; Lohmander LS
    Br J Rheumatol; 1994 Dec; 33(12):1107-11. PubMed ID: 8000736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in serum and synovial fluid biomarkers after acute injury (NCT00332254).
    Catterall JB; Stabler TV; Flannery CR; Kraus VB
    Arthritis Res Ther; 2010; 12(6):R229. PubMed ID: 21194441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.